title: Prevention and chemoprevention of colorectal neoplasms.
abstract: Main purpose of the review is to analyse the impact of the current approaches for colorectal cancer prevention, including chemoprevention. Available evidence does not support the contention that a more appropriate diet can be of great help in the prevention of these neoplasms, either because the scientific evidence is poor and highly controversial, or because changes in diet are difficult to implement, at least in many Western countries. Similarly, a preventive approach based on the modification of lifestyle remains improbable, either in the short --or in the long period of time. Secondary prevention--i.e., the systematic removal of adenomatous polyps--can hardly be applied in the general population, with the exception of individuals at risk because members of families with Adenomatosis coli or Lynch syndrome, or affected by inflammatory bowel diseases. Finally, chemoprevention (i.e., the attempt to prevent tumour development through the administration of drugs or natural compounds that interfere with various phases of carcinogenesis) is still in its infancy Though attractive, this approach requires well-designed studies which should be carried out for years before being evaluated and interpreted; so far most of these investigations gave inconsistent or controversial results. In conclusion, both primary and secondary prevention of colorectal malignancies appear difficult to apply in the general population, and chemoprevention is still at the beginning of a (presumably] long story. The final impression is that notwithstanding the remarkable advancements made in the last two decades in colorectal cancer research, the practical application of these new concepts remains difficult.
authors.affiliation: Department of Medical, Oncological and Radiological Science, University of Modena and Reggio Emilia, Italy. deleon@unimo.it
authors.forename: DeLeonM
authors.initials: D
authors.lastname: Ponz
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use; D018890:Chemoprevention; D015179:Colorectal Neoplasms / Q000517:prevention & control* / Q000601:surgery; D004032:Diet; D015444:Exercise; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D013467:Sulindac / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000975:Antioxidants; D014815:Vitamins; D013467:Sulindac; D005492:Folic Acid